EATRIS’ contribution to research findings

Here is a list of publications citing EATRIS from April to June (Q2) 2023

Abstract 3957: Anticancer effect of novel 1,4-benzodiazepine derivatives through tubulin polymerization inhibition

Authors: Srovnalova, A;Rehulka, J;Gurska, S;Polyshchuk, P;Bachinsky, S;Dzubak, P;Hajduch, M;

Year: 2023

Journal: Cancer Research

DOI: 10.1158/1538-7445.am2023-3957

Abstract 350: Study of A3 adenosine receptor interactions and identification of novel ant-/agonist using a specific fluorescent probe

Authors: Jecmenova, K;Kotulova, J;Gurska, S;Majellaro, M;Hajduch, M;Sotelo, E;Gioe-Gallo, C;Dzubak, P;

Year: 2023

Journal: Cancer Research

DOI: 10.1158/1538-7445.am2023-350

Therapeutic potential and limitations of curcumin as antimetastatic agent

Authors: Dytrych, P;Kejík, Z;Hajduch, J;Kaplánek, R;Veselá, K;Kučnirová, K;Skaličková, M;Venhauerová, A;Hoskovec, D;Martásek, P;Jakubek, M;

Year: 2023

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

DOI: 10.1016/j.biopha.2023.114758

[68Ga]Ga-Ornibactin for Burkholderia cepacia complex Infection Imaging Using Positron Emission Tomography

Authors: Bendova, K;Raclavsky, V;Novotny, R;Luptakova, D;Popper, M;Novy, Z;Hajduch, M;Petrik, M;

Year: 2023

Journal: Journal of medicinal chemistry

DOI: 10.1021/acs.jmedchem.3c00469

Electron beam irradiation as a straightforward way to produce tailorable non-biofouling poly(2-methyl-2-oxazoline) hydrogel layers on different substrates

Authors: Šrámková, P;Kučka, J;Kroneková, Z;Lobaz, V;Šlouf, M;Mičušík, M;Šepitka, J;Kleinová, A;Chorvát, D;Mateášik, A;Hrubý, M;Kronek, J;

Year: 2023

Journal: Applied Surface Science

DOI: 10.1016/j.apsusc.2023.157061

Recent Advances in 64Cu/67Cu-Based Radiopharmaceuticals

Authors: Krasnovskaya, OO;Abramchuck, D;Erofeev, A;Gorelkin, P;Kuznetsov, A;Shemukhin, A;Beloglazkina, EK;

Year: 2023

Journal: International journal of molecular sciences

DOI: 10.3390/ijms24043674

A conserved tryptophan in the acylated segment of RTX toxins controls their β2- integrin-independent cell penetration

Authors: Osickova, A;Knoblochova, S;Bumba, L;Man, P;Kalaninova, Z;Lepesheva, A;Jurnecka, D;Cizkova, M;Biedermannova, L;Goldsmith, JA;Maynard, JA;McLellan, JS;Osicka, R;Sebo, P;Masin, J;

Year: 2023

Journal: The Journal of biological chemistry

DOI: 10.1016/j.jbc.2023.104978

Highly Cytotoxic Copper(II) Mixed-Ligand Quinolinonato Complexes: Pharmacokinetic Properties and Interactions with Drug Metabolizing Cytochromes P450

Authors: Medvedíková, M;Ranc, V;Vančo, J;Trávníček, Z;Anzenbacher, P;

Year: 2023

Journal: Pharmaceutics

DOI: 10.3390/pharmaceutics15041314

Editorial: Advances in methods and tools for multi-omics data analysis

Authors: Cominetti, O;Agarwal, S;Oller-Moreno, S;

Year: 2023

Journal: Frontiers in molecular biosciences

DOI: 10.3389/fmolb.2023.1186822

Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours

Authors: Zubaľ, M;Výmolová, B;Matrasová, I;Výmola, P;Vepřková, J;Syrůček, M;Tomáš, R;Vaníčková, Z;Křepela, E;Konečná, D;Bušek, P;Šedo, A;

Year: 2023

Journal: Pathology

DOI: 10.1016/j.pathol.2023.05.003

Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients

Authors: Rehulkova, A;Chudacek, J;Prokopova, A;Vidlarova, M;Stranska, J;Drabek, J;Potockova, J;Trojanec, R;Vrbkova, J;Skarda, J;Bohanes, T;Szkorupa, M;Tolmaci, B;Klein, J;Srovnal, J;Hajduch, M;

Year: 2023

Journal: Translational lung cancer research

DOI: 10.21037/tlcr-22-801

Kingella kingae RtxA toxin interacts with sialylated gangliosides

Authors: Rahman, WU;Fiser, R;Osicka, R;

Year: 2023

Journal: Microbial pathogenesis

DOI: 10.1016/j.micpath.2023.106200

BopN is a Gatekeeper of the Bordetella Type III Secretion System

Authors: Navarrete, KM;Bumba, L;Prudnikova, T;Malcova, I;Allsop, TR;Sebo, P;Kamanova, J;

Year: 2023

Journal: Microbiology spectrum

DOI: 10.1128/spectrum.04112-22

Ensuring efficient development of personalized medicine by addressing regulatory needs: What role can research infrastructures play?

Authors: Capone, F;Morrow, D;Moretti, F;

Year: 2023

Journal: The International journal of biological markers

DOI: 10.1177/03936155231179981

Improving COVID-19 metadata findability and interoperability in the European Open Science Cloud

Authors: Ohmann, C;Canham, S;Majcen, K;Holub, P;Saunders, G;Tang, J;Tunstall, T;Gribbon, P;Karki, R;Kleemola, M;Moilanen, K;Daelemans, W;Fivez, P;Broeder, D;de Jong, F;Panagiotopoulou, M;

Year: 2023

Journal: ARPHA Preprints

DOI: 10.3897/arphapreprints.e107873

The Evolution Of Open Source Biotech – From Liberty To Justice

Authors: Contreras, J;

Year: 2023

Journal: SSRN Electronic Journal

DOI: 10.2139/ssrn.4479019

FAIR Data Cube, a FAIR data infrastructure for integrated multi-omics data analysis

Authors: Liao, X;Niehues, A;de Visser, C;Huang, J;Doornbos, C;Ederveen, T;Kulkarni, P;van der Velde, K;Swertz, M;Brandt, M;van Gool, A;’t Hoen, P;

Year: 2023

Preprint platform: medRxiv

DOI: 10.1101/2023.04.23.23289000

TGF-β induces matrisome pathological alterations and EMT in patient-derived prostate cancer tumoroids

Authors: Fernandes, S;La Cruz, J;Cassani, M;Morazzo, S;Ďuríková, H;Caravella, A;Fiore, P;Azzato, G;De Marco, G;Lauria, A;Izzi, V;Bosáková, V;Fric, J;Filipensky, P;Forte, G;

Year: 2023

Preprint platform: bioRxiv

DOI: 10.1101/2023.04.03.534859

“La influencia de la comunidad científica en el proceso de creación y puesta en marcha de megaproyectos científicos en México. El caso del Gran Telescopio Milimétrico Alfonso Serrano y el Observatorio de Rayos Gamma HAWC

Author: Resendiz Garcia, NM;

Year: 2023

Thesis

Development and application of methodologies and infrastructures for cancer genome analysis within Personalized Medicine

Author: Royo Garrido, R;

Year: 2023

Thesis

Vroege Health Technology Assessment

Authors: Grutters, J;Frederix, G;

Year: 2023

zonmw.nl

Estratègia de recerca i innovació en salut de les Illes Balears 2023-2027

Authors: i Consum, CS;en Salut, DGR;i Acreditacio, F;

Year: 2023

Book

Rezistentní nádorové buněčné linie jako model pro výzkum onkologické terapie

Author: Hruba, ML;

Year: 2023

Thesis

D7. 8 IRP-Integrated Sustainability and Business Plan Adapted to NF

Authors: Falco, JL;de la Figuera, N;Rodriguez, A;de Tejada, RS;

Year: 2023

Conference

D5. 5 Operational Plan to implement TB IRP

Authors: Pereiro, E;Montalva, AS;Saluzzo, F;Cirillo, DM;

Year: 2023

Conference

D3. 3 Generic process for an EHR-based patient cohort for IRPs

Authors: Daniel, C;Ammour, N;Kremer, A;Kalko, S;Worrell, C;

Year: 2023

Conference

D6. 6 Clinical research network report to support future NASH IRPs

Authors: Sanchez, A;Oostenbrink, R;Gold, S;

Year: 2023

Conference

D3. 7 Trial feasibility in federated hospital networks

Authors: Hasselbaink, D;Todorovic, M;Didden, E;Spiertz, C;

Year: 2023

Conference

D1. 12 Patient Engagement Platform

Authors: Jarke, H;Navarro, SR;Arevalo, E;de Sena, E;Cordero, E;

Year: 2023

Conference

D1. 13 Outcomes of workshops delivered by EPF and Patient representatives

Authors: Navarro, SR;Castiglione, F;Krause, A;Jarke, H;

Year: 2023

Conference

D4. 6: Operational Plan to implement TRD/PRD IRP and LNHS

Authors: Ramos-Quiroga, JA;Perez-Fuentes, G;Ibanez, P;

Year: 2023

Conference

D4. 5 TRD/PRD final master protocol for IRP

Authors: Glimm, E;Benedetti, F;Hofner, B;

Year: 2023

Conference

D6. 7 IRP Integrated Sustainability Business Plan adapted to NASH-PT

Authors: de Sena, E;Quiles, I;Tacke, F;Ratziu, V;Anstee, Q;

Year: 2023

Conference

D7. 4 NF Master Protocol for IRPs

Authors: Bakker, A;Nievo, M;Heimann, G;Leubner, J;Legius, E;

Year: 2023

Conference

D4. 7 TRD/PRD final report on Regulatory and Ethics Consultation

Authors: Benedetti, F;Szuch, M;Hernandez-Penna, S;

Year: 2023

Conference

 

Back